Clyde Hosein Buys 6,500 Shares of DENTSPLY SIRONA Inc.

Clyde Hosein made a notable move by purchasing 6,500 shares of DENTSPLY SIRONA Inc. (NasdaqGS: XRAY) on June 15, 2026. The shares were bought at an average price of $9.99 each, making the total transaction worth $64,935. This insider transaction was not part of a pre-planned trading program.

Other Institutional Activity in DENTSPLY SIRONA

Institutional investors have shown interest in DENTSPLY SIRONA Inc. recently. BlackRock, Inc. increased its holding by 547,312 shares, bringing its total to 19,251,869 shares valued at approximately $223.3 million. First Eagle Investment Management, LLC added 487,378 shares, ending with 15,127,933 shares worth about $175.5 million. Fuller & Thaler Asset Management, Inc. also grew its position by 287,008 shares, holding a total of 12,792,518 shares valued at $148.4 million.

DENTSPLY SIRONA Inc. Stock Down 3.3%

Shares of DENTSPLY SIRONA Inc. are currently trading around $10.55. The company has a market capitalization of approximately $2.03 billion and a forward P/E ratio of 6.56. The stock has a beta of 0.905, indicating moderate volatility compared to the market. Its 52-week range has seen a low of $9.41 and a high of $17.09. The 50-day moving average is $10.98, while the 200-day moving average stands at $11.98. The company maintains a current ratio of 1.53 and a quick ratio of 0.67, with a debt-to-equity ratio of 177.79.

Recent Earnings

In its most recent earnings report, DENTSPLY SIRONA Inc. recorded revenue of $3.68 billion, showing a slight growth of 0.1%. However, the company posted a net margin of -17.06% and a return on equity of -37.67%. The next earnings announcement is expected on August 6, 2026.

Dividend

DENTSPLY SIRONA Inc. offers a dividend with an annual rate of $0.64, yielding 5.04%. The dividend payout ratio is 28.83%, which suggests a reasonable distribution of profits back to shareholders.

Insider Buying and Selling at DENTSPLY SIRONA Inc.

Besides Clyde Hosein, several other insiders have recently bought shares. On June 15, 2026, Brian Gladden purchased 9,985 shares at $10.02 each. Earlier, on June 12, 2026, Brian McKeon and Jonathan Jay Mazelsky each acquired 10,000 shares at prices of $10.12 and $10.14, respectively. Betsy Holden and Michael Barber also made purchases on June 11, 2026, buying 10,086 and 15,175 shares at prices of $9.88 and $9.89, respectively.

Analysts Set New Price Targets

Analysts have mixed views on DENTSPLY SIRONA Inc. On June 4, 2026, Barclays maintained a 'sell' rating with a target price of $9. UBS, on May 7, 2026, maintained a 'buy' rating with a target of $17. Citigroup initiated coverage with a 'sell' rating and a $10 target on April 15, 2026. The consensus recommendation is 'hold' with an average target price of $13.40.

About DENTSPLY SIRONA Inc.

DENTSPLY SIRONA Inc., headquartered in Charlotte, North Carolina, is a leading provider of dental equipment and products. Operating in the healthcare sector, it offers a variety of solutions including imaging equipment, dental handpieces, and orthodontic products. The company is led by CEO Daniel T. Scavilla and employs around 14,000 people worldwide.

Bottom Line

The recent insider buying activity at DENTSPLY SIRONA Inc. suggests some level of confidence from within the company. Investors often track such insider moves as they may provide insights into the company's future prospects. However, it's important to remember that these transactions are backward-looking and may not reflect the current stance of the insiders.